Allogene Therapeutics (ALLO) EBITDA Margin Growth (1y) (2022 - 2024)
Allogene Therapeutics (ALLO) EBITDA Margin Growth (1y) (2022 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Allogene Therapeutics |
482.98 Mn |
482.98 Mn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2024 |
2.46 Mn |
| Dec 31, 2023 |
-3.91 Mn |
| Sep 30, 2023 |
4.09 Mn |
| Jun 30, 2023 |
-22.18 Mn |
| Mar 31, 2023 |
-10.12 Mn |
| Dec 31, 2022 |
-36.25 Mn |
| Sep 30, 2022 |
-15.78 Mn |
| Jun 30, 2022 |
3.28 Mn |
| Mar 31, 2022 |
-21.86 Mn |
